The FASEB Journal, Vol 10, 1398-1407, Copyright © 1996 by The Federation of American Societies for Experimental Biology

REVIEWS

Peripheral 5-HT4 receptors

SS Hegde and RM Eglen
Institute of Pharmacology, Neurobiology Unit, Roche Bioscience, Palo Alto, California 94304, USA.

The 5-HT4 receptor is a member of the seven transmembrane spanning G- protein-coupled family of receptors. The receptor is positively coupled to adenylate cyclase and exists in two isoforms (5-HT4S and 5-HT4L) that differ in the length and sequence of their carboxy termini. The 5- HT4 receptor is pharmacologically defined by selective agonists such as SC 53116 and RS 67506, and selective antagonists such as GR 113808, SB 204070, and RS 39604. The receptor is widely distributed in the central nervous system and peripheral tissues. In the periphery, the receptor plays an important role in the function of several organ responses including the alimentary tract, urinary bladder, heart and adrenal gland. In the alimentary tract, stimulation of 5-HT4 receptors has a pronounced effect on smooth muscle tone, mucosal electrolyte secretion, and the peristaltic reflex. In the urinary bladder, activation of 5-HT4 receptors modulates cholinergic/purinergic transmission. In the heart, stimulation of atrial 5-HT4 receptors produces positive inotropy and tachycardia that can precipitate arrhythmias. In the adrenal gland, agonism of 5-HT4 receptors stimulates release of cortisol, corticosterone, and aldosterone. Since its discovery in 1988, significant advances have been made in our understanding of the physiology and pharmacology of the 5-HT4 receptor. These advances have led to the development of several selective 5-HT4 receptor agonists and antagonists that may have therapeutic utility in the treatment of peripheral disorders such as irritable bowel syndrome, gastroparesis, urinary incontinence and cardiac arrhythmias.

This article has been cited by other articles:

				E. C. Ontsouka, J. W. Blum, A. Steiner, and M. Meylan 5-Hydroxytryptamine-4 receptor messenger ribonucleic acid levels and densities in gastrointestinal muscle layers from healthy dairy cows J Anim Sci, December 1, 2006; 84(12): 3277 - 3284. [Abstract] [Full Text] [PDF]

				M. Liu, M. S. Geddis, Y. Wen, W. Setlik, and M. D. Gershon Expression and function of 5-HT4 receptors in the mouse enteric nervous system Am J Physiol Gastrointest Liver Physiol, December 1, 2005; 289(6): G1148 - G1163. [Abstract] [Full Text] [PDF]

				Y. Kojima, T. Nakagawa, R. Katsui, H. Fujii, Y. Nakajima, and M. Takaki A 5-HT4 agonist, mosapride, enhances intrinsic rectorectal and rectoanal reflexes after removal of extrinsic nerves in guinea pigs Am J Physiol Gastrointest Liver Physiol, August 1, 2005; 289(2): G351 - G360. [Abstract] [Full Text] [PDF]

				D. Pau, A. J. Workman, K. A. Kane, and A. C. Rankin Electrophysiological Effects of Prucalopride, a Novel Enterokinetic Agent, on Isolated Atrial Myocytes from Patients Treated with {beta}-Adrenoceptor Antagonists J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 146 - 153. [Abstract] [Full Text] [PDF]

				B.-G. Tuo, Z. Sellers, P. Paulus, K. E. Barrett, and J. I. Isenberg 5-HT induces duodenal mucosal bicarbonate secretion via cAMP- and Ca2+-dependent signaling pathways and 5-HT4 receptors in mice Am J Physiol Gastrointest Liver Physiol, March 1, 2004; 286(3): G444 - G451. [Abstract] [Full Text] [PDF]

				M. Smriga and K. Torii L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats PNAS, December 23, 2003; 100(26): 15370 - 15375. [Abstract] [Full Text] [PDF]

				H. Shimatani, Y. Kojima, M. Kadowaki, T. Nakagawa, H. Fujii, Y. Nakajima, and M. Takaki A 5-HT4 agonist mosapride enhances rectorectal and rectoanal reflexes in guinea pigs Am J Physiol Gastrointest Liver Physiol, July 7, 2003; 285(2): G389 - G395. [Abstract] [Full Text] [PDF]

				P. C. Moser, O. E. Bergis, S. Jegham, A. Lochead, E. Duconseille, J.-P. Terranova, D. Caille, I. Berque-Bestel, F. Lezoualc'h, R. Fischmeister, et al. SL65.0155, A Novel 5-Hydroxytryptamine4 Receptor Partial Agonist with Potent Cognition-Enhancing Properties J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 731 - 741. [Abstract] [Full Text] [PDF]

				H. Lefebvre, D. Cartier, C. Duparc, I. Lihrmann, V. Contesse, C. Delarue, M. Godin, R. Fischmeister, H. Vaudry, and J.-M. Kuhn Characterization of Serotonin4 Receptors in Adrenocortical Aldosterone-Producing Adenomas: In Vivo and in Vitro Studies J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1211 - 1216. [Abstract] [Full Text] [PDF]

				A. J. Kirkup, A. M. Brunsden, and D. Grundy Receptors and Transmission in the Brain-Gut Axis: Potential for Novel Therapies: I. Receptors on visceral afferents Am J Physiol Gastrointest Liver Physiol, May 1, 2001; 280(5): G787 - G794. [Abstract] [Full Text] [PDF]

				Q. Li, C. Wichems, A. Heils, L. D. Van de Kar, K.-P. Lesch, and D. L. Murphy Reduction of 5-Hydroxytryptamine (5-HT)1A-Mediated Temperature and Neuroendocrine Responses and 5-HT1A Binding Sites in 5-HT Transporter Knockout Mice J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 999 - 1007. [Abstract] [Full Text]

				B Y De Winter, G E Boeckxstaens, J G De Man, T G Moreels, J A J Schuurkes, T L Peeters, A G Herman, and P A Pelckmans Effect of different prokinetic agents and a novel enterokinetic agent on postoperative ileus in rats Gut, November 1, 1999; 45(5): 713 - 718. [Abstract] [Full Text] [PDF]

				F. Crema, C. Modini, T. Croci, M. Langlois, and F. de Ponti Intestinal Prokinesia by Two Esters of 4-Amino-5-Chloro-2-Methoxybenzoic Acid: Involvement of 5-Hydroxytryptamine-4 Receptors and Dissociation from Cardiac Effects In Vivo J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1045 - 1052. [Abstract] [Full Text]